Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.7K
Epigenetic Regulation01:46

Epigenetic Regulation

33.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

36.7K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
36.7K
Abnormal Proliferation02:23

Abnormal Proliferation

5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Oncological Outcomes of Minimally Invasive Surgery in Non-Small Cell Lung Cancer: An Updated Review.

Cancers·2026
Same author

Methylation Analyses in Liquid Biopsy of Lung Cancer Patients: A Novel and Intriguing Approach Against Resistance to Target Therapies and Immunotherapies.

Cancers·2025
Same author

Co-Occurring Genomic Alterations in NSCLC: Making Order into a Crowded List.

Cancers·2025
Same author

Decoding the NRF2-NOTCH Crosstalk in Lung Cancer-An Update.

Antioxidants (Basel, Switzerland)·2025
Same author

Distribution of <i>EGFR</i> and <i>KRAS</i> Mutations in Patients with Surgically Resected Non-Small Cell Lung Cancer from Southern Italy: Real-Life Data from a Single Institution and Literature Review.

Cancers·2025
Same author

Tumor Methylation Burden (TMeB) in Non-Small Cell Lung Cancer: A New Way of Thinking About Epigenetics.

International journal of molecular sciences·2024

Related Experiment Video

Updated: Jan 10, 2026

A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells
12:48

A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells

Published on: February 16, 2018

7.8K

Unlocking Lung Cancer Cell Dormancy: An Epigenetic Perspective.

Federico Pio Fabrizio1

  • 1Department of Medicine and Surgery, "Kore" University of Enna, 94100 Enna, Italy.

International Journal of Molecular Sciences
|November 27, 2025
PubMed
Summary

Cellular dormancy drives lung cancer relapse by altering gene expression through epigenetic changes. Targeting these epigenetic mechanisms offers new strategies to combat minimal residual disease and improve patient outcomes.

Keywords:
DNA methylationepigeneticslung cancerminimal residual diseasetherapy resistancetumor dormancy

More Related Videos

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

8.6K
An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
09:14

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

Published on: August 11, 2011

16.3K

Related Experiment Videos

Last Updated: Jan 10, 2026

A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells
12:48

A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells

Published on: February 16, 2018

7.8K
An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

8.6K
An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
09:14

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

Published on: August 11, 2011

16.3K

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Lung cancer is a leading cause of cancer mortality, with recurrence and metastasis presenting major challenges.
  • Cellular dormancy, a quiescent state, contributes significantly to therapeutic resistance and disease relapse in lung cancer.
  • Epigenetic dysregulation is increasingly recognized as a key factor in maintaining cellular dormancy and tumor progression.

Purpose of the Study:

  • To review the current understanding of epigenetic regulation in lung cancer cellular dormancy.
  • To highlight the role of epigenetic modifications in driving therapeutic resistance and relapse.
  • To discuss emerging therapeutic targets and strategies for overcoming dormancy.

Main Methods:

  • Literature review of studies on lung cancer, cellular dormancy, and epigenetics.
  • Analysis of epigenetic mechanisms including DNA methylation, histone modifications, and ncRNAs.
  • Examination of the interplay between epigenetic modifiers and oncogenic signaling pathways.

Main Results:

  • Epigenetic modifications are crucial for maintaining lung cancer cell dormancy by repressing proliferation.
  • Dormant tumor cells possess distinct epigenomic signatures that may predict relapse risk.
  • Specific epigenetic pathways are implicated in the survival and persistence of dormant lung cancer cells.

Conclusions:

  • Epigenetic regulation plays a pivotal role in lung cancer cellular dormancy and therapeutic resistance.
  • Understanding the epigenetics of dormancy can lead to the development of novel biomarkers for minimal residual disease.
  • Targeting epigenetic mechanisms offers a promising avenue for developing new treatments to improve long-term outcomes for lung cancer patients.